Markets › India › NSE › NATHBIOGEN

Nath Bio-Genes (India) Ltd

NSE:NATHBIOGENBasic Materials

₹135.71−1.43%At closeAt close · Mon 19 Oct · ≈ AED 5.24 · Market cap $26.99M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	55.7%	55.5%	55.3%	41.7%	62.9%	45.8%	—	—
Operating margin	21.2%	49.4%	57.5%	19.3%	12.6%	10.9%	10.9%	+0.0 pts
Net margin	18.1%	−24.2%	11.6%	16.0%	10.6%	9.4%	9.4%	+0.0 pts
EBITDA margin	22.3%	−17.9%	16.2%	21.7%	13.6%	14.9%	—	—
Return on equity	9.1%	−12.4%	6.1%	6.5%	6.0%	6.1%	6.1%	+0.0 pts
Return on assets	7.1%	−9.1%	4.4%	4.5%	3.8%	3.8%	3.8%	+0.0 pts
Return on capital employed	10.6%	25.1%	30.1%	7.7%	7.0%	6.9%	—	—
Debt / equity	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	12.2%	12.5%	13.3%	12.5%	11.9%	12.6%	—	—
Interest coverage	7.4×	12.9×	17.0×	5.4×	4.4×	3.0×	—	—
Current ratio	3.1×	2.4×	2.4×	2.2×	1.9×	2.0×	2.0×	+0.0%
Quick ratio	1.8×	1.3×	1.4×	1.3×	1.0×	0.8×	—	—
Cash ratio	0.2×	0.0×	0.2×	0.3×	0.2×	0.2×	0.2×	+0.0%
Asset turnover	0.4×	0.4×	0.4×	0.3×	0.4×	0.4×	—	—
Inventory turnover	0.6×	0.6×	0.6×	0.6×	0.4×	0.5×	—	—
Receivables turnover	2.8×	3.3×	3.1×	2.6×	4.1×	5.2×	—	—
Dividend payout	0.0%	−5.6%	10.9%	9.6%	9.8%	9.1%	—	—